Checkmate Pharmaceuticals, Inc.
(NASDAQ GM: CMPI)
Rigrodsky Law, P.A. is investigating Checkmate Pharmaceuticals, Inc. (“Checkmate”) regarding possible breaches of fiduciary duties and other violations of law related to Checkmate’s agreement to be acquired by Regeneron Pharmaceuticals, Inc. Under the terms of the agreement, Checkmate’s shareholders will receive $10.50 in cash for each share of Checkmate common stock they own.